Net Loss per Share (Tables)
|9 Months Ended|
Sep. 30, 2019
|Net Loss per Share|
|Schedule of computation of diluted net loss per weighted average number of shares outstanding||
The following tables set forth the computation of diluted net loss per weighted average number of shares outstanding attributable to Synthetic Biologics, Inc. and Subsidiaries for the three and nine months ended September 30, 2019 and 2018 (in thousands except share and per share amounts):
Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef